Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 6 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 80 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays.
The 14 most recent Form 4 transactions.
| Jun 18 | AVIR | Atea Pharmaceuticals, Inc. | MEXER◆ | 29,600 | — | — | — | Open the original filing on SEC.gov |
| Jun 18 | AVIR | Atea Pharmaceuticals, Inc. | MEXER | 29,600 | — | — | +47.2% | Open the original filing on SEC.gov |
| May 5 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 6,040 | — | — | — | Open the original filing on SEC.gov |
| May 5 | HALO | Halozyme Therapeutics,… | AGRANT | 3,796 | — | — | +19.1% | Open the original filing on SEC.gov |
| Feb 26 | OVID | Ovid Therapeutics Inc. | AGRANT◆ | 65,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | AVIR | Atea Pharmaceuticals, Inc. | MEXER◆ | 29,600 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | AVIR | Atea Pharmaceuticals, Inc. | AGRANT◆ | 41,200 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | AVIR | Atea Pharmaceuticals, Inc. | AGRANT◆ | 29,600 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | AVIR | Atea Pharmaceuticals, Inc. | MEXER | 29,600 | — | — | +89.3% | Open the original filing on SEC.gov |
| May 1, 2025 | HALO | Halozyme Therapeutics,… | AGRANT◆ | 5,750 | — | — | — | Open the original filing on SEC.gov |
| May 1, 2025 | HALO | Halozyme Therapeutics,… | AGRANT | 4,165 | — | — | +26.4% | Open the original filing on SEC.gov |
| Feb 20, 2025 | OVID | Ovid Therapeutics Inc. | AGRANT◆ | 45,000 | — | — | — | Open the original filing on SEC.gov |